Package 72205-156-30

{"route": ["ORAL"], "spl_id": "5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f", "openfda": {"upc": ["0372205159303", "0372205158191", "0372205157309", "0372205158306"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (72205-156-30)", "package_ndc": "72205-156-30", "marketing_start_date": "20260114"}], "brand_name": "eltrombopag", "product_id": "72205-156_5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "72205-156", "generic_name": "eltrombopag olamine", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "eltrombopag", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "12.5 mg/1"}], "application_number": "ANDA220250", "marketing_category": "ANDA", "marketing_start_date": "20260114", "listing_expiration_date": "20271231"}